Search "+Nivolumab"

Positive matches

• 0.138 + - Pembrolizumab
• 0.111 + - PD-1 and PD-L1 inhibitors
• 0.111 + - Melanoma
• 0.111 + - BRAF inhibitor
• 0.111 + - Cancer immunotherapy
• 0.111 + - Ipilimumab
• 0.111 + - Opdivo
• 0.111 + - PD-1
• 0.111 + - BRAF
• 0.051 + - pVAC-Seq
• 0.025 + - Genome editing
• 0.025 + - Avelumab
• 0.025 + - Durvalumab
• 0.025 + - Cytokine
• 0.025 + - PD-L1
• 0.025 + - Immune checkpoint
• 0.025 + - BMS
• 0.025 + - January 12
• 0.025 + - 2015
• 0.025 + - 2012

Negative matches